Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
19.22
+0.22 (1.16%)
Feb 21, 2025, 4:00 PM EST - Market closed
Palvella Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Palvella Therapeutics stock have an average target of 40.33, with a low estimate of 38 and a high estimate of 44. The average target predicts an increase of 109.83% from the current stock price of 19.22.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Palvella Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 |
---|---|---|
Strong Buy | 1 | 3 |
Buy | 0 | 0 |
Hold | 0 | 0 |
Sell | 0 | 0 |
Strong Sell | 0 | 0 |
Total | 1 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +102.91% | Feb 20, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +97.71% | Feb 11, 2025 |
TD Cowen | TD Cowen | Strong Buy Initiates $44 | Strong Buy | Initiates | $44 | +128.93% | Feb 5, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +97.71% | Jan 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +97.71% | Jan 3, 2025 |
Financial Forecast
Revenue This Year
35.02K
Revenue Next Year
n/a
from 35.02K
EPS This Year
-3.77
from 0.67
EPS Next Year
-2.82
from -3.77
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 55,650 | n/a | n/a |
Avg | 35,017 | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -3.17 | -1.68 | -2.95 |
Avg | -3.77 | -2.82 | -3.53 |
Low | -4.28 | -3.85 | -4.04 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.